Ann: Letter to Shareholders from the Board of Ave, page-19

re: Ann: Letter to Shareholders from the Boar... CB,

It is the company's job to find a niche for ATC. It is the FDA's job to provide advice on what they need to do to obtain approval for that niche. Simple as that. The FDA simply can't solve Avexa's problem. Avexa has to solve it themselves. They have had plenty of time to do that and have failed.

The one question that nobody seems to be asking is what these new blokes will do if, in fact, ATC is dead? Are they the right people to have in there if it is dead? Have they actually said they will give the cash back?

My guess would be that they are representing a group of shareholders who themselves want control of the remaining dollars.

Anyway, we will know soon enough.

Bob